Table 2.

Ad-ISF35-transduced cell product

Subject number (initials)	1 (MP)	2 (RL)	3 (RG)	4 (RT)	5 (RM)	6 (JC)	7 (BF)	8 (JW)	9 (LH)
Intended dose (ISF35-cells)	1×108	1×108	1×108	3×108	3×108	3×108	1×109	1×109	1×109
Volume infused (ml)	10	10	10	10	10	10	30	30	30
% ISF35 transduction	49	77	52	57	58	40	42	54	41
ISF35 MFIR	2.0	6.9	2.1	2.9	2.9	1.8	3.7	2.1	2.2
%CD95+ in transduced	83	96	94	97	96	93	90	78	93
CD95 MFIR in transduced	7.6	43.6	15.0	34.4	33.4	17.4	20.3	11.7	27.1
Free Ad-ISF35 (p/ml)	8.7×106	4.3×106	3.0×106	5.4×106	7.8×106	5.3×106	4.2×106	1.8×107	2.8×106
Total free Ad-ISF35 infused	8.7×107	4.3×107	3.0×107	5.4×107	7.8×107	5.3×107	1.3×108	5.4×108	8.4×107

Abbreviations: MFIR, mean fluorescence intensity ratio; p/ml, particles/ml.